539561 — Remedium Lifecare Income Statement
0.000.00%
Last trade - 00:00- IN₹11.22bn
- IN₹11.23bn
- IN₹5.10bn
- 34
- 52
- 51
- 40
Annual income statement for Remedium Lifecare, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS |
| Status: | Final | Final | Final |
| Revenue | |||
| Total Revenue | 900 | 5,048 | 5,098 |
| Cost of Revenue | |||
| Gross Profit | 22.9 | 63.2 | 160 |
| Selling / General / Administrative Expenses | |||
| Depreciation and Amortization | |||
| Unusual Expense / Income | |||
| Other Operating Expenses | |||
| Total Operating Expenses | 894 | 5,032 | 5,025 |
| Operating Profit | 6.53 | 16.3 | 73.2 |
| Total Net Non Operating Interest Income / Expense | |||
| Other Net Non Operating Costs | |||
| Net Income Before Taxes | 6.53 | 15.3 | 74 |
| Provision for Income Taxes | |||
| Net Income After Taxes | 4.8 | 10.8 | 54.3 |
| Net Income Before Extraordinary Items | |||
| Net Income | 4.8 | 10.8 | 54.3 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||
| Income Available to Common Shareholders Including Extraordinary Items | |||
| Diluted Net Income | 4.8 | 10.8 | 54.3 |
| Diluted Weighted Average Shares | |||
| Basic EPS Including Extraordinary Items | |||
| Diluted EPS Including Extraordinary Items | |||
| Diluted EPS Excluding Extraordinary Items | |||
| Normalised Income Before Taxes | |||
| Normalised Income After Taxes | |||
| Normalised Income Available to Common Shareholders | |||
| Diluted Normalised EPS | 0.048 | 0.107 | 0.538 |